Search Results - "Nogaret, J.M"

Refine Results
  1. 1
  2. 2

    A significant proportion of elderly patients develop hormone-dependant “luminal-B” tumours associated with aggressive characteristics by Durbecq, V, Ameye, L, Veys, I, Paesmans, M, Desmedt, C, Sirtaine, N, Sotiriou, C, Bernard-Marty, C, Nogaret, J.M, Piccart, M, Larsimont, D

    Published in Critical reviews in oncology/hematology (01-07-2008)
    “…Abstract Introduction To investigate the influence of ageing on the incidence of breast cancer (BC) molecular subtypes, patient age at diagnosis was correlated…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Clinical validation of a molecular assay for intra-operative detection of metastases in breast sentinel lymph nodes by Martin Martinez, M.D, Veys, I, Majjaj, S, Lespagnard, L, Schobbens, J.C, Rouas, G, Filippov, V, Noterman, D, Hertens, D, Feoli, F, Bourgeois, P, Durbecq, V, Larsimont, D, Nogaret, J.M

    Published in European journal of surgical oncology (01-04-2009)
    “…Abstract Background In breast cancer patients, the status of the sentinel lymph nodes (SLNs) has been shown to accurately reflect the presence of metastases in…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Isotope labelling and axillary node harvesting strategies for breast cancer by Bourgeois, P, Nogaret, J.M, Veys, I, Hertens, D, Noterman, D, Schobbens, J.C, Paesmans, M, Larsimont, D

    Published in European journal of surgical oncology (01-06-2008)
    “…Abstract Aims The objective of this study was to assess the value of superficial (intradermal) and paratumoral (above the tumor) (ID) injection of labeled…”
    Get full text
    Journal Article
  7. 7

    217P - The routine use of sentinel lymph node biopsy in high risk DCIS lesions is not justified by Preat, F., Bohlok, A., Donckier, V., Nogaret, J.M.

    Published in Annals of oncology (01-10-2019)
    “…The use of sentinel lymph node biopsy (SLNB) during breast surgery for ductal carcinoma in situ (DCIS) is controversial. It is accepted in high risk lesions…”
    Get full text
    Journal Article
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13

    A radical approach to achieve complete cytoreductive surgery improve survival of patients with advanced ovarian cancer by Liberale, G., Pop, C.-F., Polastro, L., Kerger, J., Moreau, M., Chintinne, M., Larsimont, D., Nogaret, J.M., Veys, I.

    Published in Journal of visceral surgery (01-04-2020)
    “…Cytoreductive surgery of locally advanced ovarian cancer has evolved in the last few years from surgery to remove macroscopic residual disease (<1cm; R2b) to…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Early Invasive Cancer and Partial Intraoperative Electron Radiation Therapy of the Breast: Experience of the Jules Bordet Institute by Philippson, C., Simon, S., Vandekerkhove, C., Hertens, D., Veys, I., Noterman, D., De Neubourg, F., Larsimont, D., Bourgeois, P., Van Houtte, P., Nogaret, J. M.

    Published in International Journal of Breast Cancer (01-01-2014)
    “…Objectives. The aim of this prospective phase II study is to evaluate the treatment of early-stage breast cancer (T1 N0) with intraoperative electron radiation…”
    Get full text
    Journal Article
  16. 16

    Endometrial disorders in 406 breast cancer patients on tamoxifen: the case for less intensive monitoring by Vosse, M, Renard, F, Coibion, M, Neven, P, Nogaret, J.M, Hertens, D

    “…Objectives: To describe the endometrial appearance in postmenopausal breast cancer patients on tamoxifen and to assess a routine surveillance scheme for…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Immediate Breast Reconstruction with Implants and Adjuvant Chemotherapy: a Good Option ? by Vandeweyer, E., Deraemaecker, R., Nogaret, J.M., Hertens, D.

    Published in Acta chirurgica belgica (01-01-2003)
    “…Immediate breast reconstruction using implants is a currently practiced intervention. However, It is exposed to the potential adverse effects of adjuvant…”
    Get full text
    Journal Article
  19. 19
  20. 20